D
Grace Therapeutics, Inc. GRCE
$3.21 $0.103.12% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 7.05M 7.17M 7.20M 7.29M 7.07M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 14.81M 16.68M 16.67M 16.01M 13.27M
Operating Income -14.81M -16.68M -16.67M -16.01M -13.27M
Income Before Tax -12.79M -12.77M -16.44M -14.28M -13.71M
Income Tax Expenses -2.48M -3.20M -3.07M -2.67M -2.27M
Earnings from Continuing Operations -10.31 -9.57 -13.37 -11.61 -11.45
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -10.31M -9.57M -13.37M -11.61M -11.45M
EBIT -14.81M -16.68M -16.67M -16.01M -13.27M
EBITDA -14.80M -16.67M -16.67M -16.01M -13.27M
EPS Basic -0.82 -0.85 -1.17 -1.02 -1.16
Normalized Basic EPS -0.64 -0.70 -0.90 -0.78 -0.86
EPS Diluted -0.82 -0.85 -1.17 -1.02 -1.16
Normalized Diluted EPS -0.64 -0.70 -0.90 -0.78 -0.86
Average Basic Shares Outstanding 52.77M 47.77M 45.43M 45.43M 41.48M
Average Diluted Shares Outstanding 52.77M 47.77M 45.43M 45.43M 41.48M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --